Imbruvica (Ibrutinib) 140 Mg Capsule

HomeImbruvica (Ibrutinib) 140 Mg Capsule

 

Medical Evidence .imbruvica

Generic name : Ibrutinib.

Trade name : Imbruvica.

Manufacturer information :

Imbruvica is manufactured by Janssen Pharmaceuticals, Inc.

Imbruvica FDA Approval :

Imbruvica First approved November 13th, 2013.

Dosage form :

Capsule: 140 mg.

Imbruvica Indications and Usage :

  • Chronic Lymphocytic Leukemia.
  • Mantle Cell Lymphoma.
  • Waldenström Macroglobulinemia.

Imbruvica (Ibrutinib) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.